Form 4: AdaptHealth Corp. Director Bradley J. Coppens Reports Transaction
SEC Form 4 Filing
Director Bradley J. Coppens reports a transaction involving AdaptHealth Corp. common stock on June 24, 2024, including an acquisition of 17,523 shares and a disposition of 56,000 shares.
Summary
- On June 24, 2024, Bradley J. Coppens, a director of AdaptHealth Corp., reported a transaction involving the company's common stock.
- The transaction included the acquisition of 17,523 shares at $0 and the disposition of 56,000 shares.
- Following the reported transaction, the total number of common stock shares beneficially owned by Coppens is not specified.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock transaction by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider trading activity, which is common for directors and officers of publicly traded companies. It provides transparency to investors regarding the trading activities of company insiders.
Key Dates
| Date | Description |
|---|---|
| 2024/04/16 | Date of Power of Attorney execution. |
| 2024/06/24 | Date of transaction involving AdaptHealth Corp. common stock. |
| 2024/06/26 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.